Novel Albicidin Derivatives, Their Use and Synthesis

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent discloses novel derivatives of albicidin, a natural antibiotic compound originally produced by certain bacteria. The new compounds are structurally modified to enhance their antibacterial activity, stability against enzymatic degradation, and to overcome resistance seen in some bacterial pathogens. The derivatives feature specific chemical groups that improve their resistance to breakdown by bacterial enzymes and offer improved solubility and bioavailability, making them suitable as advanced antibiotics against gram-positive and gram-negative bacteria.

Use CasesContent extracted from patent full text and abstract with AI.

• Development of new antibiotics for clinical use against resistant bacterial infections in humans.
• Treatment of bacterial diseases in animals, including veterinary applications.
• Formulation of advanced drugs for difficult-to-treat infections, such as those caused by multi-drug resistant bacteria.
• Use in agricultural or plant protection to combat pathogenic bacteria affecting crops.
• Production of research tools for studying resistance mechanisms and testing bacterial drug susceptibility in laboratory settings.

BenefitsContent extracted from patent full text and abstract with AI.

• Overcomes bacterial resistance by modifying the albicidin structure to avoid enzymatic degradation, thus remaining effective against certain resistant pathogens.
• Broad antibacterial spectrum, effective against both gram-positive and gram-negative bacteria, including clinically significant genera such as Escherichia, Salmonella, Staphylococcus, and Mycobacterium.
• Enhanced stability and resistance to hydrolysis, improving the drug's lifespan and efficacy in biological systems.
• Improved bioavailability and solubility, enabling effective delivery via various pharmaceutical formulations (oral, injectable, topical, etc.).
• Potential to address infections where traditional antibiotics fail, providing an alternative treatment for life-threatening or otherwise untreatable bacterial illnesses.
• Chemical flexibility allows for tailored design of compounds with optimized pharmacological profiles and reduced side effects.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The present invention relates to a chemical compound according to general formula (1)